Compassionate Use Pathways

Compassionate Use Pathways is a regulatory mechanism under investigational device exemptions that permits the use of unapproved medical devices for individual patients with serious or life-threatening conditions who lack alternative treatment options and do not qualify for clinical trials.

11

Publications

529

Citations

59

Authors

47

Institutions

Publications per year

2017–2026

5

Authors

59

  1. EV
    Edo Vellenga

    University of Groningen, Netherlands

    1 publications · 21 citations

    1

    h-index

  2. MB
    Manuel Benavides

    Hospital Universitario Reina Sofía, Spain

    1 publications · 10 citations

    1

    h-index

  3. VT
    Vittoradolfo Tambone

    Università Campus Bio-Medico, Italy

    1 publications · 12 citations

    1

    h-index

  4. MC
    Monique C. Minnema

    University Medical Center Utrecht, Netherlands

    1 publications · 21 citations

    1

    h-index

  5. JK
    Jan Koedam

    University Medical Center Groningen, Netherlands

    1 publications · 21 citations

    1

    h-index

1–5 of 59

Venues

  1. Regenerative Therapy

    1 publications · 27 citations

    1

    h-index

  2. Journal of Medical Ethics

    1 publications · 67 citations

    1

    h-index

  3. Influenza and Other Respiratory Viruses

    1 publications · 18 citations

    1

    h-index

  4. BMJ

    1 publications · 12 citations

    1

    h-index

  5. Therapeutic Innovation & Regulatory Science

    TIRS · 1 publications · 11 citations

    1

    h-index

1–5